Finance

Lists
MRVI:NASDAQ
Maravai Lifesciences Holdings Inc
US$6,76
-4,11%
(-0,29) 1D
24 ກ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVI...
Open
US$7,09
High
US$7,13
Low
US$6,75
Mkt. cap
໑,໗໕ ຕື້
Avg. vol.
໓,໒໕ ລ້ານ
Volume
໑,໙໑ ລ້ານ
52-wk high
US$7,44
52-wk low
US$1,99
EPS
US$-0,72
Beta
໐,໖໕
Shares outstanding
໑໔໗,໕໑ ລ້ານ
No. of employees
໔໑໖
Open
US$7,09
High
US$7,13
Low
US$6,75
Mkt. cap
໑,໗໕ ຕື້
Avg. vol.
໓,໒໕ ລ້ານ
Volume
໑,໙໑ ລ້ານ
52-wk high
US$7,44
52-wk low
US$1,99
EPS
US$-0,72
Beta
໐,໖໕
Shares outstanding
໑໔໗,໕໑ ລ້ານ
No. of employees
໔໑໖
News stories
From sources across the web
About Maravai Lifesciences Holdings Inc
CEO-
Employees416
Founded2014
Headquarters-
SectorHealth care
Websitemaravai.com
Analyst ratings
Based on 5 analysts giving stock ratings to MRVI in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MRVI in the last 3 months.
Highest
Current US$6,76
US$6,00 (-11,24%)
Average
US$5,67 (-16,12%)
Lowest
US$5,00 (-26,04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Arias
Stifel Nicolaus
Buy
Maintained
US$6,00
-11,2%
05/11/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
05/11/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
US$6,00
-11,2%
05/08/2026
Matt Hewitt
Craig-Hallum
Buy
Reiterated
US$5,00
-26%
05/08/2026
Matt Larew
William Blair
Hold
Maintained
-
-
05/08/2026
Catherine Ramsey Schulte
Robert W. Baird
Hold
Maintained
US$3,00
-55,6%
02/26/2026
Unknown Analyst
Jefferies
Buy
Reiterated
US$5,00
-26%
02/26/2026
Next call ໃນອີກ 11 ມື້
ພະຫັດ 6 ສ.ຫ., 23:00
Fiscal period
Q2 2026
EPS / Est. (USD)
- / US$-0,04
Revenue / Est. (USD)
- / ໔໘,໖໘ ລ້ານ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
47,40 ລ້ານ
41,63 ລ້ານ
49,87 ລ້ານ
65,84 ລ້ານ
Cost of goods sold
39,63 ລ້ານ
35,98 ລ້ານ
35,32 ລ້ານ
32,14 ລ້ານ
Cost of revenue
39,63 ລ້ານ
35,98 ລ້ານ
35,32 ລ້ານ
32,14 ລ້ານ
Research and development expenses
4,88 ລ້ານ
3,84 ລ້ານ
3,79 ລ້ານ
3,89 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38,58 ລ້ານ
35,40 ລ້ານ
30,38 ລ້ານ
29,09 ລ້ານ
Operating expense
43,46 ລ້ານ
39,24 ລ້ານ
34,17 ລ້ານ
32,98 ລ້ານ
Total operating expenses
83,09 ລ້ານ
75,22 ລ້ານ
69,50 ລ້ານ
65,12 ລ້ານ
Operating income
-35,69 ລ້ານ
-33,58 ລ້ານ
-19,63 ລ້ານ
720,00 ພັນ
Other non operating income
-4,06 ລ້ານ
-71,00 ພັນ
-43,00 ພັນ
-494,00 ພັນ
EBT including unusual items
-74,12 ລ້ານ
-45,15 ລ້ານ
-63,01 ລ້ານ
-6,53 ລ້ານ
EBT excluding unusual items
-43,54 ລ້ານ
-37,70 ລ້ານ
-23,84 ລ້ານ
-3,65 ລ້ານ
Income tax expense
-4,29 ລ້ານ
-92,00 ພັນ
6,00 ພັນ
-151,00 ພັນ
Effective tax rate
5,78%
0,20%
-0,01%
2,31%
Other operating expenses
-
-
-
-
Net income
-39,59 ລ້ານ
-25,56 ລ້ານ
-35,68 ລ້ານ
-3,73 ລ້ານ
Net profit margin
-83,53%
-61,39%
-71,55%
-5,67%
Earnings per share
-0,08
-0,08
-0,04
0,01
Interest and investment income
3,03 ລ້ານ
2,80 ລ້ານ
2,38 ລ້ານ
1,87 ລ້ານ
Interest expense
-6,82 ລ້ານ
-6,84 ລ້ານ
-6,56 ລ້ານ
-5,75 ລ້ານ
Net interest expenses
-3,78 ລ້ານ
-4,05 ລ້ານ
-4,17 ລ້ານ
-3,88 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,53 ລ້ານ
-20,40 ລ້ານ
-7,18 ລ້ານ
12,09 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer